Search

Search Results

• 

  In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression, a marker of platelet activation

  A. Bontadi, A. Ruffatti, S Giannini, E. Falcinelli, M. Tonello, A. Hoxha, P. Gresele, L. Punzi

  35-39

  19-03-2012

  Published: 19 March 2012

  1321

  PDF: 623
• 

  Intracardiac thrombus in Behçet’s disease

  I. Ben Ghorbel, N. Belfeki, M.H. Houman

  148-153

  16-12-2016

  Published: 16 December 2016

  2354

  PDF: 1331
• 

  Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease

  S. Piantoni, L. Andreoli, F. Allegri, P.L. Meroni, A. Tincani

  307-313

  11-12-2012

  Published: 11 December 2012

  2037

  PDF: 1139
• 

  The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

  M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

  137-143

  16-12-2016

  Published: 16 December 2016

  1952

  PDF: 1244
• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  91-96

  Published:

  1066

  PDF: 700

• Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations

  A. Tincani, C. Casu, S. Cartella, T. Ziglioli, R. Cattaneo

  65-75

  Published:

  1687

  PDF: 3090

• Laboratory diagnosis of antiphospholipid syndrome

  V. Pengo, A. Ruffatti

  187-191

  Published:

  774

  PDF: 737

• Primary antiphosholipid syndrome and hyperomocysteinemia: a study of a group of 29 patients

  T. Del Ross, A. Ruffatti, M. Tonello, G. Salmistraro, A. Calligaro, M. Favaro, M. Ciprian, S. Todesco

  283-287

  Published:

  871

  PDF: 1053

• Neuropsychiatric Lupus Erythematosus

  M. Vadacca, F. Buzzulini, A. Rigon, G. Coppolino, A. Palma Modoni, R. Massa, A. Afeltra

  177-186

  Published:

  3752

  PDF: 16864

• Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  Published: 25 September 2024

  476

  PDF: 95

• Frequency of the bleeding risk in patients receiving warfarin submitted to arthrocentesis of the knee

  G. Salvati, L. Punzi, M. Pianon, C. Valvason, F. Schiavon, N. Noal, S. Todesco

  159-163

  Published:

  1735

  PDF: 1899

• Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

  L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani

  189-194

  Published:

  1011

  PDF: 590
• 

  Adrenal hemorrhage and non-ST elevation myocardial infarction: an antiphospholipid syndrome dilemma

  G. El Hasbani, M. Del Pilar Morel, B. Tandoh, J.F. Vargas, R. Crusio

  18-09-2023

  Published: 18 September 2023

  988

  PDF: 427

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  Published:

  1517

  PDF: 5879

• Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

  S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi

  51-59

  Published:

  1347

  PDF: 737